A Mineralys Insider Banked a $557,000 Options Gain Before a December FDA Date

RegulatoryNeutral

AI Analysis

Summary

A Mineralys insider realized a $557,000 options gain ahead of a December FDA decision date. The article reports insider trading activity without providing details on the drug, indication, or regulatory decision type.

Importance:3/10

Sentiment:

0.00

insider tradingoptions gainFDA decision pendingregulatory approval

Related Companies

$MLYS

Read the original article

Published by yahoo_finance on July 16, 2026 9:05 PM

Read Original